Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Queensland Health
Cipla
Cerilliant
Medtronic
Accenture
Daiichi Sankyo
Covington
McKesson
Boehringer Ingelheim

Generated: October 23, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: daclatasvir dihydrochloride

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Bristol-myers Squibb
DAKLINZA
daclatasvir dihydrochloride
TABLET;ORAL206843NDAE.R. Squibb & Sons, L.L.C.0003-0011-0128 TABLET in 1 BOTTLE (0003-0011-01)
Bristol-myers Squibb
DAKLINZA
daclatasvir dihydrochloride
TABLET;ORAL206843NDAE.R. Squibb & Sons, L.L.C.0003-0213-0128 TABLET in 1 BOTTLE (0003-0213-01)
Bristol-myers Squibb
DAKLINZA
daclatasvir dihydrochloride
TABLET;ORAL206843NDAE.R. Squibb & Sons, L.L.C.0003-0215-0128 TABLET in 1 BOTTLE (0003-0215-01)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Accenture
Daiichi Sankyo
US Department of Justice
Harvard Business School
Julphar
Healthtrust
Cipla
Express Scripts
Moodys

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot